Alpha 2.0
Login Register
» Authors » J Fujimoto

J Fujimoto

Explore the profile of J Fujimoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 414
Citations 5163
Followers 0
Related Specialties
Oncology
Gynecology & Obstetrics
Biochemistry
Top 10 Co-Authors
T Tamaya
S Ichigo
M Hori
H Sakaguchi
R Misao
E Okamoto
R Hirose
N Kiyokawa
Y Nakanishi
H Okada
Published In
Ann Oncol
J Steroid Biochem Mol Biol
Gynecol Endocrinol
Tumour Biol
Br J Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer
Kudo Y, Haymaker C, Reuben A, Duose D, Fujimoto J, Roy-Chowdhuri S, et al.
Ann Oncol . 2019 Jul; 30(9):1521-1530. PMID: 31282941
Background: The tumor immune microenvironment (TIME) of lung cancer brain metastasis is largely unexplored. We carried out immune profiling and sequencing analysis of paired resected primary tumors and brain metastases...
2.
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
Kadara H, Choi M, Zhang J, Parra E, Rodriguez-Canales J, Gaffney S, et al.
Ann Oncol . 2018 Apr; 29(4):1072. PMID: 29688333
No abstract available.
3.
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
Choi M, Kadara H, Zhang J, Parra E, Rodriguez-Canales J, Gaffney S, et al.
Ann Oncol . 2017 Feb; 28(1):83-89. PMID: 28177435
Background: Lung squamous cell carcinoma (LUSC) accounts for 20–30% of non-small cell lung cancers (NSCLCs). There are limited treatment strategies for LUSC in part due to our inadequate understanding of...
4.
An in vivo screening system to identify tumorigenic genes
Ihara T, Hosokawa Y, Kumazawa K, Ishikawa K, Fujimoto J, Yamamoto M, et al.
Oncogene . 2016 Oct; 36(14):2023-2029. PMID: 27694896
Screening for oncogenes has mostly been performed by in vitro transformation assays. However, some oncogenes might not exhibit their transforming activities in vitro unless putative essential factors from in vivo...
5.
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
Kadara H, Choi M, Zhang J, Parra E, Rodriguez-Canales J, Gaffney S, et al.
Ann Oncol . 2016 Oct; 28(1):75-82. PMID: 27687306
Background: Lung adenocarcinomas (LUADs) lead to the majority of deaths attributable to lung cancer. We performed whole-exome sequencing (WES) and immune profiling analyses of a unique set of clinically annotated...
6.
Distinctive Pattern of Expression of Activation and Resting B Cell Antigens on Normal and Neoplastic Human B Cells: Immunophenotypic Heterogeneity in Some Lymphomas
Kiyokawa N, Kokai Y, Kikuchi K, Fujita H, Hata J, Fujimoto J
Leuk Lymphoma . 2016 Jul; 3(2):119-26. PMID: 27457297
The pattern of expression of four B cell antigen systems on mature human B cells and B cell lymphomas were studied. The L30 antigen was detected on small resting B...
7.
Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito A, et al.
Leukemia . 2015 May; 29(12):2438-41. PMID: 25975190
No abstract available.
8.
[Current opinion and future perception of treatment for hepatocellular carcinoma]
Sasaki H, Iizima T, Imai Y, Sakamoto T, Tsuji K, Fujimoto J
Nihon Shokakibyo Gakkai Zasshi . 2015 Mar; 112(1):37-61. PMID: 25744920
No abstract available.
9.
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito A, Fujimoto J, et al.
Blood Cancer J . 2014 Jul; 4:e226. PMID: 25014773
CCAAT/enhancer-binding protein alpha (CEBPA) mutations are a favorable prognostic factor in adult acute myeloid leukemia (AML) patients; however, few studies have examined their significance in pediatric AML patients. Here we...
10.
Value of pre- and postoperative meticillin-resistant Staphylococcus aureus screening in patients undergoing gastroenterological surgery
Takahashi Y, Takesue Y, Uchino M, Ikeuchi H, Tomita N, Hirano T, et al.
J Hosp Infect . 2014 May; 87(2):92-7. PMID: 24836292
Background: Data supporting active surveillance of meticillin-resistant Staphylococcus aureus (MRSA) for the prevention of postoperative infection remain controversial. Aim: To investigate the efficacy of MRSA screening in patients undergoing gastroenterological...